Matches in Nanopublications for { ?s ?p "[Dacomitinib was well tolerated and had antitumor activity in Korean patients with NSCLC who had previously progressed on chemotherapy and an epidermal growth factor receptor tyrosine kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Dacomitinib was well tolerated and had antitumor activity in Korean patients with NSCLC who had previously progressed on chemotherapy and an epidermal growth factor receptor tyrosine kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_assertion description "[Dacomitinib was well tolerated and had antitumor activity in Korean patients with NSCLC who had previously progressed on chemotherapy and an epidermal growth factor receptor tyrosine kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_provenance.